Search by Drug Name or NDC

    NDC 72893-0002-01 Beleodaq 500 mg/10mL Details

    Beleodaq 500 mg/10mL

    Beleodaq is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acrotech Biopharma Inc. The primary component is BELINOSTAT.

    Product Information

    NDC 72893-0002
    Product ID 72893-002_33fb62b0-3206-4132-87c7-d348aa5ef770
    Associated GPIs 21531520002120
    GCN Sequence Number 072560
    GCN Sequence Number Description belinostat VIAL 500 MG INTRAVEN
    HIC3 V3A
    HIC3 Description ANTINEOPLAST,HISTONE DEACETYLASE (HDAC) INHIBITORS
    GCN 36826
    HICL Sequence Number 041264
    HICL Sequence Number Description BELINOSTAT
    Brand/Generic Brand
    Proprietary Name Beleodaq
    Proprietary Name Suffix n/a
    Non-Proprietary Name Belinostat
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/10mL
    Substance Name BELINOSTAT
    Labeler Name Acrotech Biopharma Inc
    Pharmaceutical Class Histone Deacetylase Inhibitor [EPC], Histone Deacetylase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA206256
    Listing Certified Through 2024-12-31

    Package

    NDC 72893-0002-01 (72893000201)

    NDC Package Code 72893-002-01
    Billing NDC 72893000201
    Package 1 VIAL in 1 CARTON (72893-002-01) / 10 mL in 1 VIAL
    Marketing Start Date 2014-07-21
    NDC Exclude Flag N
    Pricing Information N/A